Keyphrases
South African
100%
Academic Hospital
100%
Cancer Patients
100%
African Academics
100%
Neurocognitive Dysfunction
100%
Neuro-oncology
100%
Central Nervous System Cancer
100%
Neuroimaging Markers
100%
Oncology Research
100%
Quality of Life
60%
Cancer Treatment
60%
Central Nervous System
40%
Cancer Survivors
40%
Cancer-related Cognitive Impairment
40%
Risk Factors
20%
Clinical Practice Guidelines
20%
In Cancer
20%
Descriptive Statistical Analysis
20%
Psychosocial Intervention
20%
Interview Schedule
20%
Vital Signs
20%
Psychological Challenges
20%
Structured Interview
20%
Sub-Saharan Region
20%
Neurocognitive
20%
Chemotherapy-induced
20%
Local Context
20%
Functional Assessment of Cancer Therapy
20%
Montreal Cognitive Assessment (MoCA)
20%
Inferential Statistical Analysis
20%
Center for Epidemiologic Studies Depression Scale (CES-D)
20%
Treatment Providers
20%
Non-central
20%
Computerized Cognitive Assessment
20%
Higher-order Brain Function
20%
Hamilton Anxiety Rating Scale
20%
Patient Health Questionnaire-4 (PHQ-4)
20%
Affective Change
20%
Developing Environment
20%
Central Nervous System Malignancies
20%
Neurocognitive Changes
20%
Cognitive Change
20%
Experimental Time Series
20%
Correlational Design
20%
Cancer Experience
20%
Medicine and Dentistry
Malignant Neoplasm
100%
Neuro-Oncology
100%
Central Nervous System Cancer
100%
Quality of Life
42%
Cancer Therapy
42%
Cognitive Defect
28%
Central Nervous System
28%
Cohort Effect
14%
Cancer
14%
Time Series Analysis
14%
Vital Sign
14%
Cancer Treatment
14%
Patient Experience
14%
Functional Assessment
14%
Brain Function
14%
Patient Health Questionnaire
14%
Hamilton Anxiety Rating Scale
14%
Neuropsychological Test
14%
Chemotherapy
14%
Psychology
Neurological System
100%
Quality of Life
42%
Cognitive Impairment
28%
Psychosocial Intervention
14%
Thematic Analysis
14%
Depression Scale
14%
Statistical Analysis
14%
Semistructured Interview
14%
Rating Scale
14%
Functional Assessment
14%
Psychology
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Central Nervous System Cancer
100%
Cognitive Defect
18%
Chemotherapy
9%
Epidemiology
9%